Amalgamated Bank’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,536
Closed -$15K 2423
2025
Q4
$15K Sell
1,536
-146
-9% -$1.51K ﹤0.01% 2249
2025
Q3
$21K Hold
1,682
﹤0.01% 2101
2025
Q2
$13K Hold
1,682
﹤0.01% 2324
2025
Q1
$12K Hold
1,682
﹤0.01% 2294
2024
Q4
$12K Hold
1,682
﹤0.01% 2358
2024
Q3
$12K Sell
1,682
-13,022
-89% -$122K ﹤0.01% 2368
2024
Q2
$155K Sell
14,704
-1,388
-9% -$17.6K ﹤0.01% 1631
2024
Q1
$223K Sell
16,092
-1,575
-9% -$24.6K ﹤0.01% 1572
2023
Q4
$343K Sell
17,667
-1,714
-9% -$31.6K ﹤0.01% 1585
2023
Q3
$411K Sell
19,381
-632
-3% -$16.4K ﹤0.01% 1503
2023
Q2
$664K Sell
20,013
-1,409
-7% -$51.9K 0.01% 1298
2023
Q1
$842K Sell
21,422
-1,710
-7% -$71.1K 0.01% 1179
2022
Q4
$975K Sell
23,132
-10,847
-32% -$417K 0.01% 1167
2022
Q3
$1.13M Buy
33,979
+842
+3% +$35.1K 0.01% 1063
2022
Q2
$1.44M Buy
33,137
+493
+2% +$22.6K 0.01% 993
2022
Q1
$1.56M Sell
32,644
-1,569
-5% -$77.8K 0.01% 1025
2021
Q4
$1.74M Sell
34,213
-44
-0.1% -$1.96K 0.01% 1005
2021
Q3
$1.39M Sell
34,257
-3,634
-10% -$184K 0.01% 1089
2021
Q2
$2.15M Buy
37,891
+31,583
+501% +$1.8M 0.02% 931
2021
Q1
$334K Sell
6,308
-417
-6% -$22.7K 0.01% 1212
2020
Q4
$367K Sell
6,725
-85
-1% -$4.47K 0.01% 1131
2020
Q3
$341K Sell
6,810
-38
-0.6% -$1.8K 0.01% 1053
2020
Q2
$262K Sell
6,848
-5,486
-44% -$176K 0.01% 1188
2020
Q1
$269K Sell
12,334
-185
-1% -$5.57K 0.01% 1202
2019
Q4
$513K Buy
12,519
+1,165
+10% +$47.5K 0.01% 1097
2019
Q3
$483K Sell
11,354
-190
-2% -$7.97K 0.01% 1056
2019
Q2
$569K Sell
11,544
-124
-1% -$6.31K 0.01% 1010
2019
Q1
$558K Buy
11,668
+184
+2% +$11.2K 0.01% 948
2018
Q4
$704K Buy
11,484
+1,483
+15% +$100K 0.02% 788
2018
Q3
$824K Sell
10,001
-1,686
-14% -$134K 0.02% 769
2018
Q2
$914K Buy
11,687
+1,047
+10% +$81.1K 0.02% 789
2018
Q1
$784K Buy
10,640
+137
+1% +$9.72K 0.02% 788
2017
Q4
$717K Buy
10,503
+554
+6% +$35.8K 0.02% 830
2017
Q3
$612K Sell
9,949
-574
-5% -$35.2K 0.02% 856
2017
Q2
$661K Buy
10,523
+1,825
+21% +$104K 0.02% 835
2017
Q1
$483K Buy
8,698
+430
+5% +$22.1K 0.02% 861
2016
Q4
$395K Buy
8,268
+989
+14% +$55.4K 0.02% 979
2016
Q3
$472K Buy
7,279
+16
+0.2% +$900 0.03% 773
2016
Q2
$423K Buy
7,263
+414
+6% +$16.7K 0.02% 820
2016
Q1
$262K Buy
6,849
+598
+10% +$19.8K 0.03% 969
2015
Q4
$237K Sell
6,251
-438
-7% -$16.1K 0.03% 956
2015
Q3
$276K Buy
6,689
+77
+1% +$3.31K 0.03% 930
2015
Q2
$312K Sell
6,612
-56
-0.8% -$3.03K 0.03% 940
2015
Q1
$401K Buy
6,668
+228
+4% +$11.6K 0.05% 521
2014
Q4
$281K Buy
6,440
+8
+0.1% +$353 0.04% 620
2014
Q3
$290K Buy
6,432
+82
+1% +$4.36K 0.04% 610
2014
Q2
$470K Sell
6,350
-239
-4% -$18.8K 0.07% 366
2014
Q1
$546K Sell
6,589
-49
-0.7% -$4.3K 0.09% 275
2013
Q4
$918K Buy
+6,638
New +$782K 0.16% 127

Other funds holding NUS

Amalgamated Bank's NUS Position: Q1 2026 in Review

Amalgamated Bank sold out of Nu Skin (NUS) in Q1 2026, closing a stake of 1,536 shares — an estimated $15K sold.

Amalgamated Bank first reported a position in NUS in Q4 2013 and held it in 49 quarters. The position peaked at $2.15M in Q2 2021. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.

  • Amalgamated Bank reported no remaining Nu Skin position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,536 Nu Skin shares in Q1 2026, an estimated $15K.
  • Amalgamated Bank first reported a position in Nu Skin in Q4 2013 and held it in 49 quarters.
  • Amalgamated Bank's Nu Skin position peaked at $2.15M in Q2 2021.
  • 178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.